Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2024-01-04 14:31:36
Oslo, January 4, 2024 - Observe Medical ("the Company" or "Observe Medical") has
received first order from our distributor in Portugal, Aviquímica, for delivery
of UnoMeter 500 products.
The UnoMeter portfolio is experiencing rapid expansion, having recently secured
orders from Portugal, bringing the total count to 18 countries. The favorable
clinical evaluations contribute positively to the reputation of our UnoMeter
products, demonstrating confidence in their continued success across diverse
markets.
Jørgen Mann, Chief Commercial Officer at Observe Medical, remarked, "The initial
order from Portugal stems from the distributor's own tests of the product's
performance and quality, which demonstrated positive results, confirming its
status as a high-quality product. We are pleased to enter 2024 with a commitment
to expanding our footprint in key markets and building strong partnerships with
strategic distribution allies".
For further information, please contact:
Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com
Per Arne Nygård, CFO Observe Medical
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com
About Aviquímica
Aviquímica is a leading company in the commercialization of medical and surgical
products, hygiene, patient comfort and safety, and laboratory products to
Portuguese healthcare units. The company is certified according to the NP EN ISO
9001:2015 standard and follows the quality standards required in Portugal and
the European Union
Aviquímica is among the companies selected as suppliers to the Ministry of
Health, through public tenders opened by the SPMS - Shared Services of the
Ministry of Health, E.P.E., for various groups of hospital consumer products.
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.
The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.
Further information is available at www.observemedical.com.